Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0094.HK Stock Summary
In the News
0094.HK Financial details
Company Rating
Neutral
Market Cap
102.02M
Income
-130.44M
Revenue
185.55M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
143
Optionable
No
Shortable
Yes
Earnings
27 Mar 2024
P/E
-1.01
Forward P/E
-
PEG
-0.3
P/S
0.6
P/B
0.12
P/C
-
P/FCF
-3.22
Quick Ratio
0.83
Current Ratio
1.61
Debt / Equity
0.52
LT Debt / Equity
1.33
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-4.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-16%
Revenue last 5Y
-24.64%
Revenue Q/Q
-20.67%
EPS Q/Q
25.68%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
-11%
ROC
-0.14%
Gross Margin
-30%
Oper. Margin
-74%
Profit Margin
-59%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.032-0.08
52W High
-
52W Low
-
RSI
62
Rel Volume
55.57
Avg Volume
148.88K
Volume
8.27M
Perf Week
24.44%
Perf Month
9.8%
Perf Quarter
-
Perf Half Y
9.8%
-
-
-
-
Beta
0.293
-
-
Volatility
0.01%, 0%
Prev Close
0%
Price
0.056
Change
27.27%
0094.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.2 | 0.18 | 0.17 | 0.09 | 0.05 | |
Net income per share | -0.12 | -0.02 | -0.03 | -0.05 | -0.05 | |
Operating cash flow per share | 0.06 | 0.02 | 0 | -0.01 | 0 | |
Free cash flow per share | 0.05 | 0.02 | -0.01 | -0.02 | 0 | |
Cash per share | 0.09 | 0.09 | 0.05 | 0.04 | 0.03 | |
Book value per share | 0.51 | 0.51 | 0.49 | 0.46 | 0.41 | |
Tangible book value per share | 0.24 | 0.23 | 0.2 | 0.17 | 0.15 | |
Share holders equity per share | 0.51 | 0.51 | 0.49 | 0.46 | 0.41 | |
Interest debt per share | 0.24 | 0.24 | 0.22 | 0.23 | 0.23 | |
Market cap | 482.3M | 155.82M | 218.89M | 157.67M | 83.47M | |
Enterprise value | 738.57M | 414.39M | 516.75M | 486.51M | 441.47M | |
P/E ratio | -2.11 | -4.31 | -3.7 | -1.61 | -0.9 | |
Price to sales ratio | 1.29 | 0.48 | 0.68 | 0.96 | 0.92 | |
POCF ratio | 4.31 | 4.05 | 72 | -7.43 | 0 | |
PFCF ratio | 4.89 | 5.21 | -18.44 | -5.17 | 0 | |
P/B Ratio | 0.51 | 0.16 | 0.24 | 0.19 | 0.11 | |
PTB ratio | 0.51 | 0.16 | 0.24 | 0.19 | 0.11 | |
EV to sales | 1.97 | 1.27 | 1.61 | 2.96 | 4.85 | |
Enterprise value over EBITDA | 27.33 | 23.55 | 11.1 | -22.78 | -4.43 | |
EV to operating cash flow | 6.61 | 10.78 | 169.98 | -22.93 | 0 | |
EV to free cash flow | 7.49 | 13.87 | -43.52 | -15.94 | 0 | |
Earnings yield | -0.47 | -0.23 | -0.27 | -0.62 | -1.12 | |
Free cash flow yield | 0.2 | 0.19 | -0.05 | -0.19 | 0 | |
Debt to equity | 0.45 | 0.45 | 0.43 | 0.47 | 0.52 | |
Debt to assets | 0.35 | 0.35 | 0.35 | 0.41 | 0.5 | |
Net debt to EBITDA | 9.48 | 14.69 | 6.4 | -15.4 | -3.59 | |
Current ratio | 2.29 | 2.11 | 2 | 1.61 | 1.8 | |
Interest coverage | -3.92 | -4.67 | -3.58 | -7.15 | -6.29 | |
Income quality | -0.41 | -1.28 | -0.06 | 0.18 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.16 | 0.15 | 0.15 | 0.29 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.13 | 0.12 | 0.13 | 0.11 | 0.01 | |
Capex to operating cash flow | -0.12 | -0.22 | -4.91 | 0.44 | 0 | |
Capex to revenue | -0.04 | -0.03 | -0.05 | -0.06 | 0 | |
Capex to depreciation | -0.11 | -0.09 | -0.14 | -0.09 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.19 | 0.47 | 0.6 | 0.74 | 0.68 | |
ROIC | -0.06 | -0.07 | -0.05 | -0.08 | -0.1 | |
Return on tangible assets | -0.21 | -0.03 | -0.06 | -0.11 | -0.12 | |
Graham Net | -0.23 | -0.25 | -0.25 | -0.24 | -0.24 | |
Working capital | 147.28M | 127.24M | 101.02M | 52.6M | 41.26M | |
Tangible asset value | 437.14M | 429.99M | 368.14M | 310.75M | 281.4M | |
Net current asset value | -367.4M | -391.95M | -390.9M | -408.03M | -419.1M | |
Invested capital | 0.45 | 0.45 | 0.43 | 0.47 | 0.52 | |
Average receivables | 18.95M | 20.44M | 16.29M | 37.15M | 35.5M | |
Average payables | 26.53M | 33.85M | 33.28M | 20.88M | 13.85M | |
Average inventory | 27.02M | 26.48M | 32.71M | 26.81M | 10.58M | |
Days sales outstanding | 36.94 | 3.34 | 33.71 | 99.31 | 105.46 | |
Days payables outstanding | 31.63 | 44.96 | 34.8 | 24.46 | 24.48 | |
Days of inventory on hand | 30.79 | 28.88 | 51.06 | 22.76 | 14.37 | |
Receivables turnover | 9.88 | 109.44 | 10.83 | 3.68 | 3.46 | |
Payables turnover | 11.54 | 8.12 | 10.49 | 14.92 | 14.91 | |
Inventory turnover | 11.85 | 12.64 | 7.15 | 16.04 | 25.41 | |
ROE | -0.24 | -0.04 | -0.06 | -0.11 | -0.12 | |
Capex per share | -0.01 | 0 | -0.01 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.02 | 0.04 | 0.01 | 0.03 | 0 | |
Net income per share | 0 | -0.01 | -0.01 | -0.02 | 0 | |
Operating cash flow per share | -0.01 | -0.01 | 0 | 0.01 | 0 | |
Free cash flow per share | -0.01 | -0.01 | 0 | 0.01 | 0 | |
Cash per share | 0.04 | 0.04 | 0.04 | 0.04 | 0 | |
Book value per share | 0.46 | 0.46 | 0.43 | 0.43 | 0 | |
Tangible book value per share | 0.17 | 0.17 | 0.14 | 0.14 | 0 | |
Share holders equity per share | 0.46 | 0.46 | 0.43 | 0.43 | 0 | |
Interest debt per share | 0.19 | 0.22 | 0.2 | 0.23 | 0 | |
Market cap | 148.41M | 157.67M | 135.42M | 102.02M | 0 | |
Enterprise value | 76.73M | 486.51M | 62.11M | 435.42M | 357.99M | |
P/E ratio | -4.43 | -2.35 | -1.64 | -0.62 | 0 | |
Price to sales ratio | 4.29 | 2.28 | 5.34 | 2.01 | 0 | |
POCF ratio | -15.52 | -7.62 | 27.34 | 10.3 | 0 | |
PFCF ratio | -10.4 | -6.21 | 28.47 | 10.51 | 0 | |
P/B Ratio | 0.17 | 0.19 | 0.17 | 0.13 | 0 | |
PTB ratio | 0.17 | 0.19 | 0.17 | 0.13 | 0 | |
EV to sales | 2.22 | 7.03 | 2.45 | 8.58 | 8.89 | |
Enterprise value over EBITDA | 240.54 | -32.68 | -5.81 | -45.12 | -3.97 | |
EV to operating cash flow | -8.02 | -23.52 | 12.54 | 43.95 | 0 | |
EV to free cash flow | -5.38 | -19.16 | 13.06 | 44.84 | 0 | |
Earnings yield | -0.06 | -0.11 | -0.15 | -0.4 | 0 | |
Free cash flow yield | -0.1 | -0.16 | 0.04 | 0.1 | 0 | |
Debt to equity | 0.41 | 0.47 | 0.47 | 0.51 | 0.52 | |
Debt to assets | 0.36 | 0.41 | 0.41 | 0.45 | 0.5 | |
Net debt to EBITDA | -224.71 | -22.09 | 6.86 | -34.55 | -3.97 | |
Current ratio | 1.61 | 1.61 | 1.85 | 1.85 | 1.8 | |
Interest coverage | 0 | -7.89 | 0 | -3.09 | -9.19 | |
Income quality | 1.14 | 1.24 | -0.24 | -0.24 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.31 | 0.16 | 0.43 | 0.21 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.11 | 0.11 | 0.12 | 0.12 | 0.01 | |
Capex to operating cash flow | 0.49 | 0.23 | -0.04 | -0.02 | 0 | |
Capex to revenue | -0.14 | -0.07 | -0.01 | 0 | 0 | |
Capex to depreciation | -0.11 | -0.08 | -0.03 | -0.01 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.22 | 0.31 | 0.33 | 0.47 | 0 | |
ROIC | -0.04 | -0.05 | -0.02 | -0.03 | -0.07 | |
Return on tangible assets | -0.01 | -0.02 | -0.03 | -0.05 | -0.07 | |
Graham Net | -0.24 | -0.24 | -0.25 | -0.24 | 0 | |
Working capital | 52.6M | 52.6M | 56.54M | 56.54M | 41.26M | |
Tangible asset value | 310.75M | 310.75M | 258.41M | 258.41M | 281.4M | |
Net current asset value | -408.03M | -408.03M | -426.33M | -426.33M | -419.1M | |
Invested capital | 0.41 | 0.47 | 0.47 | 0.51 | 0.52 | |
Average receivables | 39.27M | 40.4M | 32.18M | 22.92M | 0 | |
Average payables | 22.22M | 14.29M | 15.07M | 15.86M | 0 | |
Average inventory | 16.8M | 13.29M | 12.64M | 11.98M | 0 | |
Days sales outstanding | 93.88 | 58.14 | 69.73 | 46.44 | 58.78 | |
Days payables outstanding | 22.96 | 10.64 | 49.73 | 22.36 | 8.86 | |
Days of inventory on hand | 21.36 | 9.9 | 37.58 | 16.9 | 5.2 | |
Receivables turnover | 0.96 | 1.55 | 1.29 | 1.94 | 1.53 | |
Payables turnover | 3.92 | 8.46 | 1.81 | 4.02 | 10.16 | |
Inventory turnover | 4.21 | 9.09 | 2.4 | 5.33 | 17.3 | |
ROE | -0.01 | -0.02 | -0.03 | -0.05 | -0.07 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
0094.HK Frequently Asked Questions
What is Greenheart Group Limited stock symbol ?
Greenheart Group Limited is a HK stock and trading under the symbol 0094.HK
What is Greenheart Group Limited stock quote today ?
Greenheart Group Limited stock price is $0.056 today.
Is Greenheart Group Limited stock public?
Yes, Greenheart Group Limited is a publicly traded company.